about
Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disordersTowards Clinical Application of Neurotrophic Factors to the Auditory Nerve; Assessment of Safety and Efficacy by a Systematic Review of Neurotrophic Treatments in Humans.Ischaemic preconditioning: therapeutic implications for stroke?Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.BACE1 RNA interference improves spatial memory and attenuates Aβ burden in a streptozotocin-induced tau hyperphosphorylated rat model.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Gene therapy for neurological disease.
@ast
Gene therapy for neurological disease.
@en
type
label
Gene therapy for neurological disease.
@ast
Gene therapy for neurological disease.
@en
prefLabel
Gene therapy for neurological disease.
@ast
Gene therapy for neurological disease.
@en
P2860
P356
P1476
Gene therapy for neurological disease.
@en
P2093
Mark H Tuszynski
P2860
P304
P356
10.1517/14712598.3.5.815
P407
P577
2003-08-01T00:00:00Z